Post categorized under: Health Diagnostics
All too often in the conversation COVID-19 testing, two factors are lost: Pragmatism and Cost. Our Microarray platform can deliver highly effective Pooled Surveillance at a dramatically lower cost than individual testing and we are the proven alternative in Variant Identification—results in a fraction of the time and cost of NGS. The world is coming around to our way of thinking.
- What makes urinary tract infections (UTI) so worrisome?
In January, news that Defense Secretary Lloyd Austin was hospitalized with a UTI cast light on the common condition that can quickly turn life-threatening, especially among older patients. Austin, 70, developed the infection after prostate cancer surgery.
PathogenDx has taken our D3 Array Platform, which we used to successfully create COVID tests during the pandemic, to identify urinary tract infections (UTIs).
- New Advances in PCR Testing for UTI
PCR testing for UTI has undergone significant advancements, presenting new opportunities for accurate diagnosis and improved treatment outcomes. While the standard urinary tract culture and antibiotic resistance testing have been relied upon for decades, there are limitations associated with this approach, including a 15% to 20% false negative rate.
In light of these challenges, researchers have explored the utility of advanced testing techniques like PCR.
- How AI is Transforming Medical Diagnostics and Treatments
AI will change the future of health diagnostics. It can help doctors diagnose and treat diseases, and can also help predict if a patient will get better or not after getting treatment. AI can find things that doctors might miss in medical images, meaning that people can get the care they need sooner. This has led many industry leaders to believe that AI is the future of cancer diagnosis.
- Estrogen May Help Reduce UTI Susceptibility
Researchers at UT-Dallas have identified bacteria in the bladder that may indicate which postmenopausal women are more susceptible to recurrent UTI. They now believe that estrogen may play a role in reducing them.
- What to Know About Monkeypox
There is a lot of fear baiting and stigma being created around the viral monkeypox spread. Read the experiences of 7 people who have survived monkeypox as they depict the reality of their experiences and clear up misconceptions about the disease.
- ‘Shocking’ Rise in STI during COVID-19 Pandemic Alarms
What did the pandemic have to do with the rise in STI spread? Experts in public health say SARS-CoV-2 contributed to the rise in sexually transmitted infections by preventing people from getting routine health care, like in person STI screenings. Public health workers fixated on COVID-19, leaving behind typical worries like STI spread.
- Genetic Screening Before Pregnancy Detects Potential Risks in Nearly Half of Couples
Are would-be parents carrying a genetic risk of serious illnesses that they could potentially pass on to their children? Is it worth the risk not knowing? Genetic screening before pregnancy can detect the risk in 44% of couples out of 3,000 hereditary factors.
- Digital Health: An Opportunity to Advance Health Equity
To the benefit of many, the COVID-19 pandemic ushered in widespread acceptance of telehealth and other digital innovations in medicine, accelerating that health solutions have the potential to make healthcare more equitable for all. To the benefit of many, COVID-19 may have unintentionally forced us into a digital health revolution.
- Ensuring the Fairness of Algorithms that Predict Patient Disease Risk
Do I treat the patient? This is an extremely difficult decision, so many turn to disease risk prediction models. These models forecast which patients are more or less likely to develop disease, but latest efforts are trying to assure the models are fair.
- A look Inside the US Cleanroom Market
The cleanroom infection control sector is intrinsically intertwined with the engineering sector, and any major change in demand and needs causes a domino effect in the other. In the US microbiology sector, it is not just the capacity that is being pushed to the extreme, but also the capabilities. Not only is it now expected to test for the pathogenic bacteria in the product, but also narrow it down to a sub-type.
Recent Comments